Back to trial detailsIntake questionnaire
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Applying to AARA Clinical Research · Avondale, Arizona
Answer a few short questions to share with the research team.
0 of 3 answered